Shares outstanding · 2024–2025

Conmed shares outstanding

30.8M−0.2% · FY2025

Conmed (CNMD) reported 30.8M in shares outstanding for fiscal 2025, −0.2% year on year.

30.9M202430.8M2025
Conmed — Shares outstanding, 2024–2025
Fiscal yearShares outstandingChangeFiling
FY20252026-02-1130.8M−0.2%Open →
FY20242025-02-1230.9M—Open →

Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2024–2025 compound annual growth −0.2%

Shares outstanding at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Conmed shares outstanding |url=https://companiesranked.com/en/company/conmed/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Conmed shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/conmed/shares-outstanding

BibTeX

@misc{companiesranked-en-company-conmed-shares-outstanding-2026,
  author       = {{CompaniesRanked}},
  title        = {{Conmed shares outstanding}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/conmed/shares-outstanding}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0000816956-26-000009 · February 17, 2026

{{cite web |title=Conmed shares outstanding — 10-K (0000816956-26-000009) |url=https://www.sec.gov/Archives/edgar/data/816956/000081695626000009/cnmd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Conmed overview